EMERALD ADVISERS, LLC

Position in TVTX — Travere Therapeutics, Inc.

CIK 1015083 LEOLA, PA

Position in TVTX

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$90,946,333

+$44,682,040 QoQ

Shares Held

1,600,886

+2.8% QoQ

Ownership

1.70%

of shares outstanding

% of Portfolio

2.14%

of 13F equity value

Holder Rank

#15

of 315 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 76% Shared 0% None 24%

Healthcare · as of Jun 30, 2026

EMERALD ADVISERS, LLC holds $600,984,884 across 23 Biotechnology names. TVTX ranks #1 (15.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TVTX	Travere Therapeutics, Inc. This page	1,600,886	$90,946,333
2	CORT	Corcept Therapeutics Inc	748,325	$65,066,858
3	COGT	Cogent Biosciences, Inc.	1,603,319	$62,048,445
4	MIRM	Mirum Pharmaceuticals, Inc.	468,295	$54,823,295
5	SYRE	Spyre Therapeutics, Inc.	567,430	$50,376,435
6	CYTK	Cytokinetics Inc	457,956	$39,013,271
7	MANE	Veradermics, Inc	288,370	$35,452,207
8	PVLA	Palvella Therapeutics, Inc.	229,486	$35,070,050

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$90,946,333	1,600,886	+2.8%	Shares	Sole	2026-08-05
2026-03-31	$46,264,293	1,557,196	-2.3%	Shares	Sole	2026-05-04
2025-12-31	$60,913,770	1,594,184	-25.7%	Shares	Sole	2026-02-09
2025-09-30	$51,307,731	2,146,767	+2.6%	Shares	Sole	2025-10-30
2025-06-30	$30,952,128	2,091,360	+0.7%	Shares	Sole	2025-08-04
2025-03-31	$37,222,940	2,077,173	-2.3%	Shares	Sole	2025-05-01
2024-12-31	$37,030,460	2,125,744	+8.4%	Shares	Sole	2025-02-11
2024-09-30	$27,429,619	1,960,659	+19.8%	Shares	Sole	2024-10-29
2024-06-30	$13,457,340	1,637,146	-6.4%	Shares	Sole	2024-08-06
2024-03-31	$13,487,881	1,749,401	+67.2%	Shares	Sole	2024-05-08
2023-12-31	$9,404,879	1,046,149	-1.3%	Shares	Sole	2024-02-05
2023-09-30	$9,479,099	1,060,302	+64.9%	Shares	Sole	2023-10-26
2023-06-30	$9,877,278	643,052	—	Shares	Sole	2023-07-25
No filing history on record for this holder in this stock.